| Literature DB >> 31200765 |
Shi-Shi Shen1,2,3, Xiao-Yan Qu1,2,3, Wei-Zhe Zhang1,2,3, Jian Li4, Zhi-Yue Lv5,6,7.
Abstract
BACKGROUND: Infectious diseases encompass a large spectrum of diseases that threaten human health, and coinfection is of particular importance because pathogen species can interact within the host. Currently, the antagonistic relationship between different pathogens during concurrent coinfections is defined as one in which one pathogen either manages to inhibit the invasion, development and reproduction of the other pathogen or biologically modulates the vector density. In this review, we provide an overview of the phenomenon and mechanisms of antagonism of coinfecting pathogens involving parasites. MAIN BODY: This review summarizes the antagonistic interaction between parasites and parasites, parasites and viruses, and parasites and bacteria. At present, relatively clear mechanisms explaining polyparasitism include apparent competition, exploitation competition, interference competition, biological control of intermediate hosts or vectors and suppressive effect on transmission. In particular, immunomodulation, including the suppression of dendritic cell (DC) responses, activation of basophils and mononuclear macrophages and adjuvant effects of the complement system, is described in detail.Entities:
Keywords: Antagonism; Coinfection; Immunomodulation; Parasite; Pathogen
Mesh:
Year: 2019 PMID: 31200765 PMCID: PMC6570864 DOI: 10.1186/s40249-019-0560-6
Source DB: PubMed Journal: Infect Dis Poverty ISSN: 2049-9957 Impact factor: 4.520
Fig. 1Flow chart of selection process of the included and excluded articles
Phenomena of “infection against infection”
| Categories | Interspecies antagonism | Patterns of antagonism | Intensity of antagonism | References |
|---|---|---|---|---|
| Between Parasites and parasites | Inhibiting transmission | 66.66% | [ | |
| Inhibiting transmission | 66.66% | [ | ||
| Inhibiting transmission | 12.45% | [ | ||
| Decreasing parasitaemia | 47.50% | [ | ||
| Attenuating symptoms | 24.00% | [ | ||
| Attenuating symptoms | 27.50% | [ | ||
|
| Decreasing parasitaemia | 28.00% | [ | |
| Attenuating symptoms | 76.00% | [ | ||
| Inhibiting propagation | 88.82% | [ | ||
| Inhibiting propagation | 31.70% | [ | ||
| Inhibiting propagation | 22.00% | [ | ||
| Decreasing parasitaemia | 74.07% | [ | ||
| Between Parasites and bacteria | Inhibiting transmission | 94.37% | [ | |
| Inhibiting transmission | 83.10% | [ | ||
| Inhibiting transmission | 98.59% | [ | ||
| Inhibiting transmission | 38.00% | [ | ||
| Decreasing parasitaemia and attenuating symptoms | 56.82%, | [ | ||
| Inhibiting propagation | 42.86% | [ | ||
| Decreasing parasitaemia | 46.78% | [ | ||
| Decreasing parasitaemia | 33.00% | [ | ||
| Inhibiting propagation | 79.50% | [ | ||
| 80.00% | ||||
| Between Parasites and Viruses | Attenuating symptoms | 39.50% | [ | |
| Attenuating symptoms | 42.06% | [ | ||
| Decreasing viral loads | 23.50% | [ |
aContradictory results
bAntagonism between different strains of P. berghei
cLaboratory conditions
dConditions in human population